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Abstract 
The highly conserved insulin/insulin-like growth factor signaling (IIS) pathway plays a 
critical role in development, lifespan, and metabolism. In the nematode, Caenorhabditis elegans, 
there are 40 insulin-like genes.  Here, I investigate the transcriptional regulation of one insulin-
like gene, ins-27, by knocking down transcription factor expression via RNA interference. I 
identified sixty five transcription factors as potential regulators of ins-27. By investigating 
regulators of C. elegans insulin-like genes, we may learn more about the biological processes 
that modulate insulin expression. This may provide greater insight into the regulation of human 
insulin-like genes.  
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Introduction 
 The insulin/insulin-like growth factor signaling (IIS) pathway is highly conserved in 
Caenorhabditis elegans and humans and plays a critical role in development, lifespan, stress 
resistance, and metabolism for both species (Ritter et al., 2013; Kenyon 2011).  There have been 
several studies that have linked individuals with reduced somatic signaling with a longer lifespan 
on average compared to those without genetic variation.  Specifically, variants of the Forkead 
box O (FOXO) gene, known to be under IIS control, are known for their longevity amongst 
unrelated human populations (Anisimov and Bartke, 2013).  While the human genome contains 
ten genes that encode for insulin-like peptides, including insulin, insulin-like growth factors 
(IGFs) and relaxins, C. elegans encodes 40 insulin-like genes (Ritter et al., 2013; Li et al., 2003).  
Other downstream components of the IIS pathway in C. elegans include the DAF-2 receptor, and 
a downstream signaling cascade that acts on the FOXO/DAF-16 transcription factor 
(Narasimhan et al., 2009; Kenyon, 2011).  
Despite the high conservation of the IIS pathway, much is still left unknown.  Learning 
more about the participants involved in this pathway, can give insight into the biological 
processes that modulate insulin expression and the regulation of human insulin-like genes.  This 
question can be approached on a systems level, which helps to understand complex interactions 
within biological systems.  Since C. elegans is a transparent animal, green fluorescent protein 
(GFP) reporters can be used to determine when and where there insulin-like genes are expressed. 
The worm also contains roughly 940 known transcription factors, which have been used to create 
an RNA interference (RNAi) library (Arda and Walhout, 2009).  In this project, this library was 
used to identify transcription factors involved in the activation of ins-27, one of the insulin-like 
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genes.  Thus, by using model organisms such as C. elegans, we can learn more about the IIS 
pathway in both C. elegans and humans. 
Insulin/Insulin-like Signaling Pathway 
There are forty insulin-like genes in C. elegans, compared to ten in humans.  This raises 
questions as to why the worm needs so many different insulin-like genes and how their different 
expression patterns are regulated.  These questions were examined in a recent study of the 
insulin-like genes (Ritter et al., 2013).  It was originally proposed that there is a certain level of 
redundancy amongst the genes.  Thirty one of the insulin-like genes are expressed in at least two 
tissue types, with three genes expressed in as many as 15.  The major tissues that the insulins are 
expressed in are the neurons, muscle, and intestine (Ritter et al., 2013).  Many of these genes 
have similar expression patterns, but each gene may have varying degrees of expression 
intensities in specific tissues during development or when exposed to environmental changes.  
For instance, insulin expression in the pharynx decreases as the worm age, and expression 
increases in the distal tip cell in older worms.  Factors such as aging, starvation, dauer formation, 
and heat stress can also change the insulin-expression patterns (Ritter et al., 2013).  Of the forty 
genes, ins-4 was one of the genes that stood out as showing high expression overlap with seven 
different insulin genes including ins-1, ins-5, ins-7, ins-8, ins-10, ins-17, and ins-18. This was 
calculated by a Tissue Overlap Coefficient (TsOC) score, which calculates the degree of 
expression overlap for each pair-wise combination of inulins at each developmental stage (Ritter 
et al., 2013).  With no complete overlap in expression patterns between any two insulin-like 
genes, there is no absolute redundancy amongst the insulin-like genes. 
The insulin-like gene family shares 25-40% of amino acid sequence identity, and thirty 
four of the studied thirty seven genes are shown to have conserved intron and exon patterning, as 
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seen in vertebrates (Nelson and Padgett, 2003).  As a result of their structural similarity, ten 
proteins, including ins-4, have been identified as ligands for DAF-2, a receptor in the signaling 
pathway (Duret et al., 1998). 
 
Figure 1: IIS pathway (Nemoto and Finkel, 2004).  Insulin-like ligands mediate cellular responses such as metabolism and 
defenses against stress via a signaling pathway. 
DAF-2 is a type of receptor tyrosine kinases and is the only homolog in C. elegans of the 
mammalian insulin/IGF receptor family.  In its activated state in C. elegans, DAF-2 promotes 
several processes including reproductive growth.  If this receptor is not activated, it leads to 
developmental arrest in the dauer stage.  Some of the downstream molecules of DAF-2 include 
AGE-1, PIP2, AKT-1/AKT-2, and DAF-16 (Figure 1).  This pathway seen in C. elegans is also 
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conserved in mammals, with homologs for each of the mentioned molecules (Pierce et al., 2000).  
The human homologs of DAF-16 are FKHR and AFX, which may be misregulated in some 
forms of diabetes (Nelson et al., 2003).  DAF-16 is responsible for the up-regulation of 
transcription for genes that encode for heat shock proteins and antioxidants.  There was a study 
that showed that daf-2 mutants live twice as long as wild-type C. elegans, showing that the IIS 
pathway is also connected to longevity (Kenyon et al., 1993). 
Caenorhabditis elegans 
 C. elegans is a small nematode that serves as a model organism for biological research 
including genomics, cell biology, neuroscience, and aging.  These animals have short life cycles, 
compact genomes, consistent development, large number of progeny, and genes that are easily 
manipulated (Altun and Hall, 2009).  With only 959 somatic cells, C. elegans was the first 
multicellular eukaryote to have its genome completely sequenced, yielding 97 Mb of sequence 
encoding approximately 19,000 genes (Kamath and Ahringer, 2003).  A notable feature of this 
organism is its transparency (Figure 2).  Their tissues and organs can be seen under a 
microscope, which is another reason why they are a good organism to study.  Gene expression 
can be examined using RNA interference (RNAi) or genetic mutations. 
 An easy method for looking at gene expression in C. elegans is by creating a transgenic 
strain with a GFP insert.  Endogenous gene expression patterns can be mimicked by creating 
transgenic animals with a promoter of interest driving GFP expression.  Therefore, when a 
transcription factor binds to a promoter, the GFP will fluoresce under ultraviolet light.  One 
method of creating these transgenic strands is through the use of microparticle bombardment 
(Pratis et al., 2001). 
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Figure 2: Adult C. elegans with eggs.  The organs of the worm can be seen, as well as any eggs when the worm is in the adult 
stage.  The anterior of the worm is on the left and the posterior is to the right.  Some noticeable features are its pharynx, intestine, 
and gonad. 
RNAi 
 Studying the genetics of an organism can be achieved through two different approaches.  
The first type of approach is to randomly mutagenize an organism, looking for a desired 
phenotype.  Once the organism displays this phenotype, one can go back and try to identify the 
gene.  This process is known as forward genetics, or classical genetics.  Alternatively, reverse 
genetics starts with a gene of interest, and once mutated, its phenotype can be studied (Griffiths 
et al., 2008).  Forward genetics may work with organisms with small genomes, but larger 
eukaryotic genomes make screening and mapping every mutable gene unrealistic.  With the 
complete genome of C. elegans sequenced, the use of reverse genetics is possible with the use of 
RNAi.  This technique results in protein knock-down typically by interfering with translation 
(Kamath and Ahringer, 2003). 
Methods for RNAi screening 
There are three different methods of introducing RNAi into C. elegans.  As Fire et al. 
describe, the first studies that demonstrated the effectiveness of RNAi used injection of dsRNA 
Pharynx 
Intestine 
Gonad with eggs  
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into the head or tail of the animal.  This produced significant interference throughout the body 
and germ line, showing the ability of RNAi to cross cellular boundaries (Fire et al., 1998).  
Another study showed that soaking the worms in dsRNA from the maternal pos-1 gene for 24 
hours resulted in the distinct embryonic lethal phenotype in 86% of the F1 progeny (Tabara et 
al., 1998).  The final method is through feeding.  The worms are fed E. coli transformed with a 
vector containing cDNA of the desired gene to knock down.  Also in the vector are T7 promoter 
sites flanking each side of the multiple cloning site (Kamath and Ahringer, 2003, Timmons et al., 
2001).  The T7 promoters transcribe the sense and antisense strands to produce dsRNA.  The 
feeding method is the most effective for large-scale RNAi screening since the bacterial libraries 
of these RNAi strains exist. 
RNAi through feeding not only requires less laborious efforts, but it also allows many 
genes to be tested on a large population of worms.  Another advantage to feeding is that it is 
cheaper than soaking or microinjections.  This method requires that each bacterial strain to be 
created contains the correct DNA insert.  Each gene to be tested must have the DNA cloned into 
a special plasmid vector, which then needs to be inserted into a particular bacterial strain 
(Kamath and Ahringer, 2003).  This project will utilize the transcription factor RNAi library 
created by the Walhout laboratory at UMass. 
RNAi mechanism 
 RNAi is a process of post-transcriptional gene silencing (PTGS) that has been conserved 
throughout evolution.  Fire et al. determined that dsRNA induced gene silencing when injected 
into C. elegans was substantially more effective than either the single sense or antisense strands 
(1998).  They also found that only the exons of the gene affect the phenotypic change.  Figure 3 
is a guide from Lima et al. to explain the process of RNAi.  The RNAi library should produce 
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exact small interfering RNA (siRNA) for each transcription factor, inducing the cleavage 
pathway as shown, rather than translational repression. 
 
Figure 3: Mechanism of RNAi (Lima et al., 2013).  One means of RNAi is when dsRNA enters the cell through the membrane 
via endogenous, transgenic, or viral trancripts.  It is then processed into siRNA approximately 21-22 bp in length by a 
Ribonuclease III enzyme.  This enzyme, referred to as Dicer, recognizes and cleaves dsRNA at specific positions or sequences 
(Lima et al., 2013).  The siRNA molecules are now able to be incorporated into a multi-subunit RNA-induced silencing complex 
(RISC), which targets the specific RNA transcript for degradation or repression (Shuey et al., 2002).  RISC contains a helicase 
domain comprised of Argonaute, which allows it to separate the siRNA into its sense and antisense strands.  The antisense strand 
serves as a template for degradation, where RNA hydrolysis occurs within the region of homology with the mRNA (Shuey et al., 
2002; Lima et al., 2013). 
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Goals 
The overall goal of the project was to understand the regulation of ins-4 and ins-27.  The 
first step towards the goal was to set up the high throughput method of testing the entire 
transcription factor RNAi library.  The next step was to use the system to identify transcription 
factors regulating ins-4 and ins-27 using transgenes containing a GFP reporter.  These goals were 
attempted using the transcription factor RNAi library as mentioned in Watson et al. (2013).   
Materials and Methods 
The protocol for setting up the RNAi library for screening was the same as that used by Watson 
et al. (2013). 
Strain maintenance 
 The strains were maintained using methods as described by Brenner (1974).  Worms 
were fed Escherichia coli (OP50) and grown on NGM-agar plates.  They were kept at a 
temperature of 20°C or 15°C, until eggs could be harvested.  When the plates became starved, 
worms were transferred to new plates by cutting a chunk from the starved plate and laying it 
face-down on the new plate. 
Egg isolation protocol 
To isolate the eggs, worms and any laid eggs were washed from six 6 cm nearly starved 
plates with M9 buffer and collected in a 15ml conical tube.  The tubes were centrifuged at 
2000rpm for 2 minutes and the supernatant was removed.  To digest the worms, 4ml of M9, 
500µl of 5M NaOH, and 500µl of bleach were added to the tubes.  They were rocked gently, and 
were centrifuged at 2000rpm for 2 minutes when the carcasses were mostly dissolved, usually 
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after 5-10 minutes of bleaching.  This was followed by a series of four washes: 6ml of M9 was 
added to the tubes, and they were centrifuged at 2000rpm for 2 minutes, removing the 
supernatant after each wash. 
Preparing the 96-well plates 
 The 96-well plates were poured using NGM-agar enriched with 0.5μM IPTG.  A repeat 
multi-channel pipette was used to dispense 200µl of media into each well.  Plates were cooled 
slowly to prevent cracking, and were stored at 4°C once the agar solidified (Watson et al., 2013). 
Bacterial cultures 
 Bacterial RNAi cultures were grown from frozen stocks stored at -80°C.  The whole 
transcription factor library is contained in 12 96-well blocks.  An overnight culture was prepared 
in a 96-well block with 1ml of LB with 100μg/ml ampicillin (AMP) in each well.  To transfer 
bacteria, pipette tips were used to scrape bacteria from the frozen stock and mix it into the new 
96-well block with a multi-channel pipette.  The overnight culture was stored at 37°C. 
 Then, 50µl of the overnight culture was inoculated in a new 96-well block containing 1ml 
LB with 100μg/ml AMP for 6 hours or until it reached an optical density of around 1.  The cells 
were then centrifuged at 3000rpm for 15 minutes.  The supernatant was removed, and the 
bacteria were suspended in 100µl of 1x M9 (Watson et al., 2013). 
Setting up the RNAi plates 
 Using a multi-channel pipette, 10µl of the concentrated bacterial cultures was added to 
the appropriate well of the 96-well agar plates.  Precautions were used to not touch the surface of 
the agar, since that could cause the worms to burrow.  The plates were dried in the hood for 
around 15 minutes or until dry. 
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 The eggs, prepared using the Egg isolation protocolEgg isolation protocol, were added a 
day after bacteria was seeded onto the plates.  The eggs were suspended in M9 at about 20 
eggs/10µl of buffer.  10μl of suspended eggs was added to each well using a multi-channel 
pipette and dried in the hood (Watson et al., 2013). 
Screening the plates 
 Once the worms reached the young adult stage, expression of the GFP transgene could be 
examined.  A chart was used to visually score the GFP expression patterns.  Each well was given 
a numerical value ranging from 0 to 3.  A score of 3 indicated wild-type expression, a score of 2 
indicated a slight loss of expression, a score of 1 indicated a major loss of expression, and a score 
of 0 indicated complete loss of GFP expression.  It was also possible to score a ND (not 
discernible) when the well could not be given an accurate score.  The final column of the plates 
alternated between a negative control and a positive control.  The negative control was an empty 
vector and the positive control contained RNAi specific to GFP. 
Results 
 In order to determine potential regulators of ins-4 and ins-27 expression, RNAi was used 
to knockdown individual transcription factors in C. elegans.  The 96-well set up allowed for 
quick screening under a dissecting scope.  After scoring each well in triplicate with a numerical 
value from 0 to 3, the expression patterns were averaged to determine the highest knockdowns 
for each gene.  Once a list was compiled of the total RNAi scores, the top candidate genes were 
further examined. 
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ins-4 
  Before beginning the RNAi screening for ins-4, the wild-type expression pattern needed 
to be recorded.  When grown at 15°C on OP50 bacteria, expression could be seen in the head 
neurons and in the posterior end of the intestine (Figure 4).  At different temperatures, 
throughout development, and under starvation, no changes in the tissue of expression were seen 
or major changes in GFP intensities.   
 
Figure 4: Wild-type expression pattern for ins-4.  The bold arrows depict the head neurons and the thin arrows depict the 
expression in the intestine.   
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 After a screen, it was apparent that RNAi did not affect the genes in the neurons.  This 
meant that the scoring for ins-4 expression would be based on the expression in the intestine.  It 
was difficult to clearly see noticeable differences for RNAi knockdown in the intestine since the 
wild-type expression was already weak.  This made accurately scoring each RNAi nearly 
impossible given the number of transcription factors that needed to be examined with the given 
time constraints.  Thus, no further work was performed on ins-4 expression. 
ins-27 
 The expression pattern of ins-27 when grown on OP50 bacteria at 15°C was visible in the 
body wall muscle (Figure 5).  There were no major changes in expression as a result of starvation 
effects or when grown at different temperatures. 
 
Figure 5: Wild-type expression for ins-27.  This gene is expressed in the body wall muscle, and increases in intensity during 
development. 
 RNAi knockdown is effective in the muscle, and because this gene showed bright 
expression, the changes were able to be quantified by the scoring range described in the 
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Materials and Methods.  Each well was scored in triplicate and three of the twelve plates from 
the RNAi library were tested.  An example of RNAi is shown below (Figure 6).  Since panel C 
shows wild-type expression, it would be assigned a score of 3.  Panel D showed a major decrease 
in expression in two worms and very little expression in the leftmost worm.  This resulted in a 
score of 1.  The positioning of the worms was taken into account.  Worms lying on their back, 
such as in panel B would show expression patterns that were brighter than if they were on their 
sides, such as those in panel D. 
 
Figure 6: GFP knockdown examples from the RNAi plates. Wild-type GFP expressed in the muscle is seen in A and C, and a 
loss of GFP is seen in B and D.  A and B were the respective negative and positive controls, and C and D are genes labeled by 
their open reading frame. 
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Once the averages for each gene were calculated from the three scores, the data were 
plotted to determine the ranges of expression patterns (Figure 7).  It is shown that most of the 
genes displayed nearly wild-type expression patterns.  Based on the spread of this data, candidate 
genes were considered if they scored an average, calculated from at least two wells, below 2.00. 
 
Figure 7: Average GFP scores for the 262 genes tested. Scored 262 genes, 65 (25%) transcription factors influenced ins-27 
expression. 
Characterization of transcription factors 
 Once the data from the RNAi screens for ins-27 were collected, the transcription factors 
were further examined.  The first step in learning more about the transcription factors scoring 
below a 2.00 was to compare them to known transcription factor regulators of another gene.  The 
acdh-1 gene is expressed in the intestine and already had its transcription factors studied using 
the same RNAi approach (MacNeil et al., 2013).  From this comparison, thirteen transcription 
factors were found to activate both genes (Figure 8).  This result suggests that these transcription 
factors are most likely general transcription factors, since they are active in both muscle and 
intestine. 
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Figure 8: TF comparison between ins-27 and acdh-1. The ins-27 TFs with expression patterns below 2.0 were compared to 
tested transcription factors of acdh-1, expressed in the intestine. 
 The general overlap between the two genes suggests that these potential candidate 
transcription factors are general transcription factors, but looking into each gene’s assigned Gene 
Ontology (GO) provided greater insight into the function of the transcription factors.  GO terms 
are assigned descriptions for each gene.  Generalizing GO terms allowed the clear distinction 
that most of these genes have been labeled as general transcription factors (Figure 9).  The 
overlapping transcription factors have all been assigned GO terms indicating that they act as 
general transcription factors.  This supports the hypothesis that they are potentially general 
transcription factors in the worm. 
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Figure 9: Generalized GO terms from the 65 candidate TFs. (A) The top 17 RNAi TFs with their GO terms and average GFP 
scores. D/A- Development/Aging, Re- Reproduction, GT- General Transcription Factor, S- Structure, CP- Cellular Processes, O- 
Other, R- Regional.  (B) All but 1 gene had multiple GO terms, and most fell into the general TF category.  Some TF are 
involved with development and aging, processes in the IIS pathway. 
 Although 94% of the transcription factors were labeled as general transcription factors, 
twenty-three are seen to be involved in processes such as development and aging.  Since these 
processes are also known to be influenced by the IIS pathway, it can indicate there may be some 
more specific functions of the transcription factors.  There wasn’t an apparent pattern seen 
between the GO terms and the RNAi knockdown scores.  Just as the GO terms seen amongst the 
top seventeen transcription factors vary, this is the same throughout the candidate transcription 
factors.  The development and aging GO terms, for example, are assigned to genes in the top 
seventeen as well as genes that scored 1.67. 
 The top 65 transcription factors expression profiles were also examined.  Each gene was 
searched on WormBase to determine the tissue that they are expressed in.  Several have been 
indentified to be produced in the muscle.  Nearly half of the transcription factors didn’t have 
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their expression fully annotated, so a complete analysis of the tissues that these genes are 
expressed in cannot be completed. 
Discussion 
 In order to learn more about the IIS pathway in C. elegans, the transcription factors of 
one insulin-like gene were examined.  The worms used have promoter driven GFP for the ins-27 
gene, so when a transcription factor binds to the promoter to stimulate transcription, they will 
fluoresce under UV light.  A library exists that contains RNAi specific to each transcription 
factor in the worm.  By testing each transcription factor and scoring GFP knockdown, potential 
regulators of ins-27 were identified. 
 After screening 262 transcription factors, 65 have been scored below a 2.00, indicating 
that they have a significant loss of GFP expression.  Of these, nearly all have been identified as 
general transcription factors by GO terms.  Even when the activators of ins-27 and acdh-1 were 
compared, there were thirteen in common, further suggesting that these genes are most likely 
general transcription factors. 
 Utilizing RNAi knockdown of genes doesn’t necessarily show that these transcription 
factors are directly activating ins-27.  It is possible that some of these transcription factors could 
be involved in a pathway upstream of ins-27 direct activation.  Epistasis tests can determine the 
order of genes in a pathway.  In epistasis with a double mutation, the gene upstream in the 
pathway will mask the phenotype of the downstream gene.  This test will not yield results if the 
two genes are in separate pathways. 
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Future recommendations 
 After attempting to screen the ins-4 worms for potential transcription factors that regulate 
expression, it was clear that it would be extremely difficult to score.  RNAi knockdown isn’t 
effective in neurons, and the weak expression in the intestine cannot yield accurate scores.  One 
possible method to achieve knockdown in the neurons is to cross the marker into a sensitized 
strain, such as rrf-3 or other strains expressing SID-1 in particular neurons (Calixton et al., 2010; 
Asikainen et al., 2005). 
 Since all the plates weren’t able to be tested from the RNAi library, the first step is to 
complete the scoring for the remaining plates of the RNAi library for ins-27.  Once this is 
completed, random retesting of the transcription factors using RNAi as followed in this 
experiment should be implemented to eliminate any false positives.  The next step is to sequence 
the bacteria containing the cDNA of the candidate transcription factors.  This is to verify that 
they contain the correct open reading frames for the correct gene knockdowns.  The final step is 
to use RT-PCR to quantify the level of ins-27 expression to validate GFP observations. 
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Appendix 
Appendix A: Scoring for ins-27 
Plate Number TF ORF Gene Name Score 1 Score 2 Score 3 Ave 
4-A01 Y40B1A.4 sptf-3 ND 0 1 0.50 
1-A11 ZK337.2  0 1 1 0.67 
1-B01 F23F12.9 zip-8 1 0 1 0.67 
1-H04 C27C7.3 nhr-74 0 1 1 0.67 
2-A07 C27A12.2  0 1 1 0.67 
2-A08 F37D6.2  0 1 1 0.67 
2-A09 Y47D3A.10 tbx-34 1 0 1 0.67 
4-A07 Y52B11A.9  1 ND 1 1.00 
4-A11 Y87G2A.3 atg-4.1 0 1 2 1.00 
4-D01 M02H5.1 nhr-99 1 1 ND 1.00 
4-F01 F38A5.13 dnj-11 1 1 ND 1.00 
4-F10 Y56A3A.18  1 0 2 1.00 
4-F11 Y53G8AR.9  2 0 1 1.00 
4-G01 F29F11.5 ceh-22 1 1 ND 1.00 
4-G02 F56D1.1  1 ND 1 1.00 
4-H10 Y17G7B.20  1 1 1 1.00 
4-H11 T01B10.4 nhr-14 1 ND 1 1.00 
1-A10 C02B8.4 hlh-8 1 1 1 1.00 
1-B05 T22B7.1 egl-13 0 1 2 1.00 
1-F01 T23G7.1 dpl-1 1 1 1 1.00 
1-H08 H10E21.3 nhr-80 1 1 1 1.00 
1-H10 M03D4.4  1 1 1 1.00 
2-A01 C34C6.6 prx-5 1 1 ND 1.00 
2-B01 F31E8.3 tab-1 1 1 1 1.00 
2-H01 C03G6.8 nhr-147 1 ND ND 1.00 
2-H05 F38H12.3 nhr-181 1 1 1 1.00 
2-H06 T27B7.1 nhr-59 ND 1 ND 1.00 
2-H10 F57A8.5 nhr-192 1 ND 1 1.00 
2-H11 C42D8.4 ets-5 1 ND 1 1.00 
4-G04 F16B4.12 nhr-117 1 0 3 1.17 
4-A10 Y74C9A.4 rcor-1 1 2 1 1.33 
4-C01 C25G4.4 tag-347 1 2 1 1.33 
4-G07 F44E7.8 nhr-142 2 1 1 1.33 
4-H08 K06B4.5 nhr-196 1 1 2 1.33 
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1-D01 C16A3.4  1 1 2 1.33 
1-E01 W03C9.4 lin-29 1 1 2 1.33 
1-G02 F32A11.6 moe-3 1 1 2 1.33 
1-H02 W10D9.4 nfyb-1 2 1 1 1.33 
1-H03 C54C8.1 nhr-169 2 1 1 1.33 
1-H05 C17D12.1 dhhc-7 2 1 1 1.33 
1-H06 ZK418.1 nhr-9 2 1 1 1.33 
1-H07 F43C1.4 nhr-20 2 1 1 1.33 
1-H11 T08H4.3 ast-1 2 1 1 1.33 
2-A03 T26A5.8  2 1 1 1.33 
2-C01 Y80D3A.3 dlx-1 1 1 2 1.33 
2-E01 F15C11.1 sem-4 1 1 2 1.33 
2-F01 C24A1.2  1 2 1 1.33 
2-G01 K06B4.11 nhr-53 1 2 1 1.33 
2-H07 R11G11.1 nhr-132 1 2 1 1.33 
4-A08 Y54E10BR.8 ztf-3 2 ND 1 1.50 
4-B11 ZK616.10 ehn-3 2 ND 1 1.50 
1-G01 T23F11.4  1 ND 2 1.50 
1-H01 F52F12.4 lsl-1 ND 2 1 1.50 
2-H02 F47C10.3 nhr-186 ND 1 2 1.50 
2-H03 ZK6.4 nhr-253 ND 1 2 1.50 
4-D10 C56E10.4 nhr-137 2 1 2 1.67 
4-G03 Y116A8C.19  1 2 2 1.67 
4-G05 F42G4.3 zyx-1 2 1 2 1.67 
4-G06 F36F12.8 ztf-28 2 1 2 1.67 
4-G08 Y37E11B.1  2 2 1 1.67 
1-F09 C27A12.5 ceh-2 0 2 3 1.67 
1-G10 Y48C3A.17 efl-2 2 2 1 1.67 
2-A02 C28H8.9  3 1 1 1.67 
2-A04 R05D3.3  2 1 2 1.67 
2-A06 Y5F2A.4  2 1 2 1.67 
2-A10 Y75B8A.1 php-3 2 2 1 1.67 
2-A11 F26C11.2 unc-4 2 2 1 1.67 
2-D01 F38A6.1 pha-4 2 2 1 1.67 
2-H09 T27B7.3 nhr-226 1 2 2 1.67 
4-A02 F59C6.2  2 ND 2 2.00 
4-A05 T07D10.3  2 2 2 2.00 
4-D11 C47C12.3 ref-2 3 1 2 2.00 
4-E01 F09B12.2 dhhc-1 2 2 ND 2.00 
4-E11 T10B11.3 ztf-4 2 2 2 2.00 
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4-F09 T23G5.6  3 1 2 2.00 
4-G10 T27C4.4 lin-40 2 2 2 2.00 
4-G11 C01F6.9  2 2 2 2.00 
4-H01 C33G8.9 nhr-140  2 ND 2.00 
4-H02 K12H6.12  2 2 ND 2.00 
4-H03 C29F7.4 fkh-3 ND ND 2 2.00 
4-H04 ZK1128.6 ttll-4 ND 2 2 2.00 
4-H05 C28G1.4  2 ND 2 2.00 
4-H06 T10B5.10  2 ND ND 2.00 
4-H07 ZK652.6  2 ND ND 2.00 
4-H09 R07B7.15 nhr-208 2 ND 2 2.00 
1-A01 C25A1.11 aha-1 2 ND 2 2.00 
1-A04 Y116A8C.20  2 ND ND 2.00 
1-A07 C04G2.7 egl-38 ND 3 1 2.00 
1-C10 F38C2.5 ccch-2 1 2 3 2.00 
1-D11 K08B4.1 lag-1 2 3 1 2.00 
1-E09 F47D12.4 hmg-1.2 2 2 2 2.00 
1-F08 F13G3.1 ztf-2 2 2 ND 2.00 
1-G03 F10C1.5 dmd-5 2 2 2 2.00 
1-G06 B0280.4 odd-1 2 1 3 2.00 
1-G11 E02H1.7 nhr-19 2 2 2 2.00 
1-H09 F40H6.4 tbx-11 2 ND ND 2.00 
2-G11 C38C3.9 nhr-260 1 3 ND 2.00 
2-H08 C49A1.4 eya-1 ND 2 2 2.00 
4-A04 Y47H9C.2  3 2 2 2.33 
4-A09 F27D4.4  2 2 3 2.33 
4-B10 F55B11.4  2 2 3 2.33 
4-D02 M02H5.7 nhr-123 3 2 2 2.33 
4-D06 ZC376.7  2 3 2 2.33 
4-E02 C43H6.7  3 2 2 2.33 
4-E06 F23C8.4 ubxn-1 3 2 2 2.33 
4-F06 T11G6.8  3 2 2 2.33 
4-G09 F42G4.3 zyx-1 3 2 2 2.33 
1-A02 C33D3.1 elt-2 2 3 2 2.33 
1-A03 F35H8.3 zfp-2 3 3 1 2.33 
1-A06 T08D10.1 nfya-1 2 3 2 2.33 
1-A08 F44A6.2 sex-1 2 3 2 2.33 
1-C01 F56E3.4 fax-1 3 2 2 2.33 
1-D03 C36F7.1 irx-1 3 2 2 2.33 
1-D07 F55B12.1 ceh-24 1 3 3 2.33 
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1-E11 F21D12.1 nhr-21 3 3 1 2.33 
1-F02 T15H9.3 hlh-6 3 1 3 2.33 
1-F03 C35D6.4  2 2 3 2.33 
1-F10 C47F8.8 nhr-81 2 2 3 2.33 
1-G04 F22D3.1 ceh-38 2 3 2 2.33 
1-G05 F45H11.1 sptf-1 2 2 3 2.33 
1-G08 T23H4.2 nhr-69 2 2 3 2.33 
1-G09 B0336.3  2 2 3 2.33 
2-A05 T05G5.2 hlh-4 3 2 2 2.33 
2-B11 C09G9.7  3 2 2 2.33 
2-G07 F47C10.4 nhr-187 2 3 2 2.33 
4-A03 T22E7.2  3 ND 2 2.50 
4-A06 C47F8.2 nhr-165 3 2 ND 2.50 
4-B01 T05G5.6 ech-6 3 ND 2 2.50 
4-B06 F12E12.5 sdz-12 3 ND 2 2.50 
4-F03 F40G9.11 mxl-2 2 3 ND 2.50 
4-F04 K01G5.1 rnf-113 2 3 ND 2.50 
1-A05 T22C8.5 sptf-2 3 2 ND 2.50 
1-D02 F28C6.1  2 ND 3 2.50 
1-E02 Y75B8A.2 nob-1 2 ND 3 2.50 
4-B02 B0261.1  3 3 2 2.67 
4-B03 F45C12.2  3 3 2 2.67 
4-B07 F37H8.1 lir-3 3 3 2 2.67 
4-B08 W01D2.2 nhr-61 3 3 2 2.67 
4-C02 Y42H9AR.3 rabs-5 3 3 2 2.67 
4-C06 Y116A8C.22  3 3 2 2.67 
4-C07 Y55F3AM.6  3 3 2 2.67 
4-C08 R02D3.7  3 3 2 2.67 
4-C09 C29E6.5 nhr-43 3 3 2 2.67 
4-C10 W06H12.1 ztf-6 3 3 2 2.67 
4-C11 M04B2.1 mep-1 3 3 2 2.67 
4-D03 Y105E8A.17 ekl-4 3 3 2 2.67 
4-D04 W05B10.2  3 3 2 2.67 
4-D05 F17A9.6 ceh-49 3 3 2 2.67 
4-D07 Y113G7B.23 psa-1 3 3 2 2.67 
4-D09 F31A3.4 hlh-29 3 3 2 2.67 
4-E03 K09A11.1  3 3 2 2.67 
4-E04 T05A7.4 hmg-11 3 3 2 2.67 
4-E05 Y17G7A.1 hmg-12 3 3 2 2.67 
4-E07 W02A2.7 mex-5 3 3 2 2.67 
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4-E08 F09G2.9 attf-2 3 3 2 2.67 
4-E09 D1046.2  3 3 2 2.67 
4-E10 T07G12.11 zim-3 3 3 2 2.67 
4-F02 T10D4.6  3 2 3 2.67 
4-F05 W05H7.4 zfp-3 3 3 2 2.67 
4-F07 F54F2.9  3 3 2 2.67 
4-F08 Y75B8A.29  3 3 2 2.67 
1-B03 K02B9.4 elt-3 3 2 3 2.67 
1-B04 C10A4.8 mnm-2 2 3 3 2.67 
1-B09 F52E1.1 pos-1 2 3 3 2.67 
1-C06 H01A20.1 nhr-3 3 3 2 2.67 
1-C07 H14A12.4 mls-1 2 3 3 2.67 
1-C09 F43G9.11 ces-1 2 3 3 2.67 
1-D04 T13C5.4  3 2 3 2.67 
1-D06 F32B6.1 nhr-4 2 3 3 2.67 
1-E03 R03E9.1 mdl-1 3 2 3 2.67 
1-E04 F18A1.4 lir-2 3 2 3 2.67 
1-E07 R74.3 xbp-1 2 3 3 2.67 
1-E08 Y41C4A.4 crh-1 3 2 3 2.67 
1-F07 F40H3.4 fkh-8 3 2 3 2.67 
1-F11 F58A4.7 hlh-11 3 3 2 2.67 
1-G07 B0280.8 nhr-10 2 3 3 2.67 
2-B02 F21D12.5  3 3 2 2.67 
2-B03 C06G3.1 nhr-105 2 3 3 2.67 
2-B04 C08F8.8 nhr-67 2 3 3 2.67 
2-B05 Y37D8A.11  3 3 2 2.67 
2-B07 F45B8.4 pag-3 3 2 3 2.67 
2-D09 C07H6.7 lin-39 2 3 3 2.67 
2-D10 Y94H6A.1 nhr-277 3 2 3 2.67 
2-D11 Y55F3AM.14  3 3 2 2.67 
2-E06 Y57G11C.25  2 3 3 2.67 
2-E08 ZK370.2 sma-2 3 3 2 2.67 
2-E10 W02D7.6  3 2 3 2.67 
2-F10 F35E8.12 nhr-108 3 2 3 2.67 
2-F11 C33G8.8 nhr-139 3 3 2 2.67 
2-G04 C34H3.2 odd-2 3 3 2 2.67 
2-G09 F47C10.7 nhr-188 3 3 2 2.67 
4-B04 Y38E10A.18 nhr-234 3 3 ND 3.00 
4-B05 Y48C3A.4 ztf-22 3 3 3 3.00 
4-B09 Y51H1A.6 mcd-1 3 3 3 3.00 
27 
 
4-C03 F25H8.6 zbed-6 3 3 3 3.00 
4-C04 Y51H4A.17 sta-1 3 3 3 3.00 
4-C05 R13.4 miz-1 3 3 3 3.00 
4-D08 T27A8.2  3 3 3 3.00 
1-A09 R07B1.1 vab-15 ND 3 ND 3.00 
1-B02 F34D10.5 lin-48 3 3 3 3.00 
1-B06 F18A1.3 lir-1 3 3 3 3.00 
1-B07 F54A5.1  3 3 3 3.00 
1-B08 C24G6.4 nhr-47 3 3 3 3.00 
1-B10 C01H6.5 nhr-23 3 3 3 3.00 
1-B11 W09C2.1 elt-1 3 3 3 3.00 
1-C02 T19B10.11 mxl-1 3 3 3 3.00 
1-C03 W02D9.3  3 3 3 3.00 
1-C04 T27A1.6 mab-9 3 3 3 3.00 
1-C05 T22C8.3  3 3 3 3.00 
1-C08 ZC204.2  3 3 3 3.00 
1-C11 F54D1.4 nhr-7 3 3 3 3.00 
1-D05 Y48B6A.14 hmg-1.1 3 3 3 3.00 
1-D08 B0035.1  3 3 3 3.00 
1-D09 K10G6.1 lin-31 3 3 3 3.00 
1-D10 F33D11.4 ceh-12 3 3 3 3.00 
1-E05 B0414.2 rnt-1 3 3 3 3.00 
1-E06 Y75B8A.35 zip-1 3 3 3 3.00 
1-E10 C41G7.5 ahr-1 3 3 3 3.00 
1-F04 F41D3.1 nhr-82 3 3 3 3.00 
1-F05 Y47D3A.6 tra-1 3 3 3 3.00 
1-F06 F54F2.5 ztf-1 3 3 3 3.00 
2-B06 C32F10.6 nhr-2 3 3 3 3.00 
2-B08 F57G8.6 nhr-193 3 3 3 3.00 
2-B09 B0286.5 fkh-6 3 3 ND 3.00 
2-B10 ZK909.4 ces-2 3 3 3 3.00 
2-C02 F54H5.4 mua-1 3 3 3 3.00 
2-C03 C49D10.2 nhr-166 3 3 3 3.00 
2-C04 R11E3.6 eor-1 3 3 3 3.00 
2-C05 Y53C12B.5 mab-3 3 ND 3 3.00 
2-C06 C17E7.1 nhr-156 3 3 3 3.00 
2-C07 F58E10.5 end-3 3 3 3 3.00 
2-C08 B0304.1 hlh-1 3 3 3 3.00 
2-C09 Y73F8A.16 tbx-39 3 3 3 3.00 
2-C10 R04B5.3 nhr-205 3 3 3 3.00 
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2-C11 F10B5.3  3 3 3 3.00 
2-D02 Y51H4A.4  3 3 3 3.00 
2-D03 F20D12.6 ceh-19 3 3 3 3.00 
2-D04 F38C2.7  3 3 3 3.00 
2-D05 F58E10.2 end-1 3 3 3 3.00 
2-D06 C06B8.1 nhr-150 3 3 3 3.00 
2-D07 T06C12.7 nhr-84 3 3 3 3.00 
2-D08 R12B2.1 sma-4 3 3 3 3.00 
2-E02 C54F6.8 nhr-171 3 3 3 3.00 
2-E03 F58G1.2  3 3 3 3.00 
2-E04 ZK682.4 hlh-10 3 3 3 3.00 
2-E05 Y52E8A.2  3 3 3 3.00 
2-E07 C45E5.6 nhr-46 3 3 3 3.00 
2-E09 F19F10.1  3 3 3 3.00 
2-E11 Y116A8C.17 dct-13 3 3 3 3.00 
2-F02 F44E2.7  3 3 3 3.00 
2-F03 C03G6.10 nhr-148 3 3 3 3.00 
2-F04 T13F3.3 nhr-127 3 3 3 3.00 
2-F05 F45E4.9 hmg-5 3 3 3 3.00 
2-F06 ZC64.3 ceh-18 3 3 3 3.00 
2-F07 T03E6.3 nhr-271 3 3 3 3.00 
2-F08 C33G8.12 nhr-163 3 3 3 3.00 
2-F09 F44G3.9 nhr-111 3 3 3 3.00 
2-G02 K06B4.2 nhr-52 3 3 3 3.00 
2-G03 T20F10.2  3 3 3 3.00 
2-G05 F44C8.11 nhr-96 3 3 3 3.00 
2-G06 F44C8.4 nhr-103 3 3 3 3.00 
2-G08 C33G8.10 nhr-162 3 3 3 3.00 
2-G10 F36D3.2 nhr-54 3 3 3 3.00 
 
Appendix B: GO terms for each gene scoring below a 2.00 
Gene WB ID Gene Public 
Name 
GO Term ID Term 
WBGene00020368 ast-1 GO:0009792 embryonic development ending in birth or egg 
hatching 
WBGene00020368 ast-1 GO:0040007 growth 
WBGene00020368 ast-1 GO:0002119 nematode larval development 
WBGene00020368 ast-1 GO:0018991 oviposition 
WBGene00020368 ast-1 GO:0045944 positive regulation of transcription from RNA 
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polymerase II promoter 
WBGene00020368 ast-1 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00020368 ast-1 GO:0043565 sequence-specific DNA binding 
WBGene00020368 ast-1 GO:0003700 transcription factor activity 
WBGene00020368 ast-1 GO:0007411 axon guidance 
WBGene00020368 ast-1 GO:0007413 axonal fasciculation 
WBGene00020368 ast-1 GO:0071542 dopaminergic 
WBGene00013595 atg-4.1 GO:0008270 zinc ion binding 
WBGene00013595 atg-4.1 GO:0005622 intracellular 
WBGene00015809 C16A3.4  GO:0009792 embryonic development ending in birth or egg 
hatching 
WBGene00015809 C16A3.4  GO:0003676 nucleic acid binding 
WBGene00015809 C16A3.4  GO:0000003 reproduction 
WBGene00015809 C16A3.4  GO:0040010 positive regulation of growth rate 
WBGene00015809 C16A3.4  GO:0008270 zinc ion binding 
WBGene00015809 C16A3.4  GO:0016246 RNA interference 
WBGene00015809 C16A3.4  GO:0005622 intracellular 
WBGene00016029 C24A1.2  GO:0006355 regulation of transcription, DNA-dependent 
WBGene00016029 C24A1.2  GO:0043565 sequence-specific DNA binding 
WBGene00016029 C24A1.2  GO:0003700 transcription factor activity 
WBGene00016154 C27A12.2 GO:0009792 embryonic development ending in birth or egg 
hatching 
WBGene00016154 C27A12.2 GO:0003676 nucleic acid binding 
WBGene00016154 C27A12.2 GO:0040010 positive regulation of growth rate 
WBGene00016154 C27A12.2 GO:0008270 zinc ion binding 
WBGene00016154 C27A12.2 GO:0005622 intracellular 
WBGene00016200 C28H8.9 GO:0005515 protein binding 
WBGene00016200 C28H8.9 GO:0008270 zinc ion binding 
WBGene00016200 C28H8.9 GO:0005622 intracellular 
WBGene00000445 ceh-22 GO:0043282 pharyngeal muscle development 
WBGene00000445 ceh-22 GO:0003677 DNA binding 
WBGene00000445 ceh-22 GO:0040010 positive regulation of growth rate 
WBGene00000445 ceh-22 GO:0045944 positive regulation of transcription from RNA 
polymerase II promoter 
WBGene00000445 ceh-22 GO:0045449 regulation of transcription 
WBGene00000445 ceh-22 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00000445 ceh-22 GO:0043565 sequence-specific DNA binding 
WBGene00000445 ceh-22 GO:0032569 specific transcription from RNA polymerase II 
promoter 
WBGene00000445 ceh-22 GO:0003700 transcription factor activity 
WBGene00000445 ceh-22 GO:0030528 transcription regulator activity 
WBGene00000445 ceh-22 GO:0006898 receptor-mediated endocytosis 
WBGene00000445 ceh-22 GO:0005634 nucleus 
WBGene00001029 dnj-11 GO:0009792 embryonic development ending in birth or egg 
hatching 
WBGene00001029 dnj-11 GO:0003677 DNA binding 
WBGene00001029 dnj-11 GO:0031072 heat shock protein binding 
WBGene00001061 dpl-1 GO:0009792 embryonic development ending in birth or egg 
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hatching 
WBGene00001061 dpl-1 GO:0040035 hermaphrodite genitalia development 
WBGene00001061 dpl-1 GO:0000003 reproduction 
WBGene00001061 dpl-1 GO:0040027 negative regulation of vulval development 
WBGene00001061 dpl-1 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00001061 dpl-1 GO:0003700 transcription factor activity 
WBGene00001061 dpl-1 GO:0005667 transcription factor complex 
WBGene00001061 dpl-1 GO:0016564 transcription repressor activity 
WBGene00001061 dpl-1 GO:0040011 locomotion 
WBGene00001061 dpl-1 GO:0046580 negative regulation of Ras protein signal 
transduction 
WBGene00001061 dpl-1 GO:0045749 negative regulation of S phase of mitotic cell 
cycle 
WBGene00001061 dpl-1 GO:0016481 negative regulation of transcription 
WBGene00001061 dpl-1 GO:0012501 programmed cell death 
WBGene00001061 dpl-1 GO:0005634 nucleus 
WBGene00001162 efl-2 GO:0040027 negative regulation of vulval development 
WBGene00001162 efl-2 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00001162 efl-2 GO:0003700 transcription factor activity 
WBGene00001162 efl-2 GO:0005667 transcription factor complex 
WBGene00001182 egl-13 GO:0001708 cell fate specification 
WBGene00001182 egl-13 GO:0008406 gonad development 
WBGene00001182 egl-13 GO:0040035 hermaphrodite genitalia development 
WBGene00001182 egl-13 GO:0040025 vulval development 
WBGene00001182 egl-13 GO:0018991 oviposition 
WBGene00001182 egl-13 GO:0000003 reproduction 
WBGene00001182 egl-13 GO:0003677 DNA binding 
WBGene00001182 egl-13 GO:0003700 transcription factor activity 
WBGene00001182 egl-13 GO:0009653 anatomical structure morphogenesis 
WBGene00001182 egl-13 GO:0051301 cell division 
WBGene00001182 egl-13 GO:0045026 plasma membrane fusion 
WBGene00001182 egl-13 GO:0005634 nucleus 
WBGene00001223 ehn-3 GO:0008406 gonad development 
WBGene00001223 ehn-3 GO:0010628 positive regulation of gene expression 
WBGene00001223 ehn-3 GO:0008270 zinc ion binding 
WBGene00001223 ehn-3 GO:0005622 intracellular 
WBGene00001223 ehn-3 GO:0005634 nucleus 
WBGene00016600 ets-5 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00016600 ets-5 GO:0043565 sequence-specific DNA binding 
WBGene00016600 ets-5 GO:0003700 transcription factor activity 
WBGene00009508 F37D6.2 GO:0008270 zinc ion binding 
WBGene00009508 F37D6.2 GO:0005622 intracellular 
WBGene00018959 F56D1.1 GO:0000003 reproduction 
WBGene00018959 F56D1.1 GO:0003676 nucleic acid binding 
WBGene00018959 F56D1.1 GO:0008270 zinc ion binding 
WBGene00018959 F56D1.1 GO:0005622 intracellular 
WBGene00001953 hlh-8 GO:0018991 oviposition 
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WBGene00001953 hlh-8 GO:0040010 positive regulation of growth rate 
WBGene00001953 hlh-8 GO:0045449 regulation of transcription 
WBGene00001953 hlh-8 GO:0030528 transcription regulator activity 
WBGene00001953 hlh-8 GO:0005634 nucleus 
WBGene00009937 lsl-1 GO:0009792 embryonic development ending in birth or egg 
hatching 
WBGene00009937 lsl-1 GO:0003676 nucleic acid binding 
WBGene00009937 lsl-1 GO:0008270 zinc ion binding 
WBGene00009937 lsl-1 GO:0005622 intracellular 
WBGene00019751 M03D4.4  GO:0003676 nucleic acid binding 
WBGene00019751 M03D4.4  GO:0008270 zinc ion binding 
WBGene00019751 M03D4.4  GO:0005622 intracellular 
WBGene00003388 moe-3  GO:0048599 oocyte development 
WBGene00003388 moe-3  GO:0003676 nucleic acid binding 
WBGene00003388 moe-3  GO:0008270 zinc ion binding 
WBGene00021132 nfyb-1 GO:0003677 DNA binding 
WBGene00021132 nfyb-1 GO:0043565 sequence-specific DNA binding 
WBGene00021132 nfyb-1 GO:0005622 intracellular 
WBGene00003707 nhr-117 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00003707 nhr-117 GO:0043565 sequence-specific DNA binding 
WBGene00003707 nhr-117 GO:0003707 steroid hormone receptor activity 
WBGene00003707 nhr-117 GO:0003700 transcription factor activity 
WBGene00003707 nhr-117 GO:0008270 zinc ion binding 
WBGene00003707 nhr-117 GO:0005634 nucleus 
WBGene00003722 nhr-132 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00003722 nhr-132 GO:0043565 sequence-specific DNA binding 
WBGene00003722 nhr-132 GO:0003707 steroid hormone receptor activity 
WBGene00003722 nhr-132 GO:0003700 transcription factor activity 
WBGene00003722 nhr-132 GO:0008270 zinc ion binding 
WBGene00003722 nhr-132 GO:0005634 nucleus 
WBGene00003727 nhr-137 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00003727 nhr-137 GO:0043565 sequence-specific DNA binding 
WBGene00003727 nhr-137 GO:0003707 steroid hormone receptor activity 
WBGene00003727 nhr-137 GO:0003700 transcription factor activity 
WBGene00003727 nhr-137 GO:0008270 zinc ion binding 
WBGene00003727 nhr-137 GO:0016021 integral to membrane 
WBGene00003727 nhr-137 GO:0019915 lipid storage 
WBGene00003727 nhr-137 GO:0005634 nucleus 
WBGene00003613 nhr-14 GO:0008340 determination of adult life span 
WBGene00003613 nhr-14 GO:0003677 DNA binding 
WBGene00003613 nhr-14 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00003613 nhr-14 GO:0043565 sequence-specific DNA binding 
WBGene00003613 nhr-14 GO:0003707 steroid hormone receptor activity 
WBGene00003613 nhr-14 GO:0003700 transcription factor activity 
WBGene00003613 nhr-14 GO:0008270 zinc ion binding 
WBGene00003613 nhr-14 GO:0004879 ligand-dependent nuclear receptor activity 
WBGene00003613 nhr-14 GO:0005634 nucleus 
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WBGene00018430 nhr-142 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00018430 nhr-142 GO:0043565 sequence-specific DNA binding 
WBGene00018430 nhr-142 GO:0003707 steroid hormone receptor activity 
WBGene00018430 nhr-142 GO:0003700 transcription factor activity 
WBGene00018430 nhr-142 GO:0008270 zinc ion binding 
WBGene00018430 nhr-142 GO:0005634 nucleus 
WBGene00008289 nhr-169 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00008289 nhr-169 GO:0043565 sequence-specific DNA binding 
WBGene00008289 nhr-169 GO:0003707 steroid hormone receptor activity 
WBGene00008289 nhr-169 GO:0003700 transcription factor activity 
WBGene00008289 nhr-169 GO:0008270 zinc ion binding 
WBGene00008289 nhr-169 GO:0005634 nucleus 
WBGene00018189 nhr-181 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00018189 nhr-181 GO:0043565 sequence-specific DNA binding 
WBGene00018189 nhr-181 GO:0003707 steroid hormone receptor activity 
WBGene00018189 nhr-181 GO:0003700 transcription factor activity 
WBGene00018189 nhr-181 GO:0008270 zinc ion binding 
WBGene00018189 nhr-181 GO:0006915 apoptosis 
WBGene00018189 nhr-181 GO:0005634 nucleus 
WBGene00018541 nhr-186 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00018541 nhr-186 GO:0043565 sequence-specific DNA binding 
WBGene00018541 nhr-186 GO:0003707 steroid hormone receptor activity 
WBGene00018541 nhr-186 GO:0003700 transcription factor activity 
WBGene00018541 nhr-186 GO:0008270 zinc ion binding 
WBGene00018541 nhr-186 GO:0005634 nucleus 
WBGene00010180 nhr-192 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00010180 nhr-192 GO:0043565 sequence-specific DNA binding 
WBGene00010180 nhr-192 GO:0003707 steroid hormone receptor activity 
WBGene00010180 nhr-192 GO:0003700 transcription factor activity 
WBGene00010180 nhr-192 GO:0008270 zinc ion binding 
WBGene00010180 nhr-192 GO:0005634 nucleus 
WBGene00010600 nhr-196 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00010600 nhr-196 GO:0043565 sequence-specific DNA binding 
WBGene00010600 nhr-196 GO:0003707 steroid hormone receptor activity 
WBGene00010600 nhr-196 GO:0003700 transcription factor activity 
WBGene00010600 nhr-196 GO:0008270 zinc ion binding 
WBGene00010600 nhr-196 GO:0005634 nucleus 
WBGene00003619 nhr-20 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00003619 nhr-20 GO:0043565 sequence-specific DNA binding 
WBGene00003619 nhr-20 GO:0003707 steroid hormone receptor activity 
WBGene00003619 nhr-20 GO:0003700 transcription factor activity 
WBGene00003619 nhr-20 GO:0008270 zinc ion binding 
WBGene00003619 nhr-20 GO:0005634 nucleus 
WBGene00020850 nhr-226 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00020850 nhr-226 GO:0043565 sequence-specific DNA binding 
WBGene00020850 nhr-226 GO:0003707 steroid hormone receptor activity 
WBGene00020850 nhr-226 GO:0003700 transcription factor activity 
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WBGene00020850 nhr-226 GO:0008270 zinc ion binding 
WBGene00020850 nhr-226 GO:0005576 extracellular region 
WBGene00020850 nhr-226 GO:0005634 nucleus 
WBGene00022639 nhr-253 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00022639 nhr-253 GO:0043565 sequence-specific DNA binding 
WBGene00022639 nhr-253 GO:0003707 steroid hormone receptor activity 
WBGene00022639 nhr-253 GO:0003700 transcription factor activity 
WBGene00022639 nhr-253 GO:0008270 zinc ion binding 
WBGene00022639 nhr-253 GO:0040011 locomotion 
WBGene00022639 nhr-253 GO:0005634 nucleus 
WBGene00003643 nhr-53 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00003643 nhr-53 GO:0043565 sequence-specific DNA binding 
WBGene00003643 nhr-53 GO:0003707 steroid hormone receptor activity 
WBGene00003643 nhr-53 GO:0003700 transcription factor activity 
WBGene00003643 nhr-53 GO:0008270 zinc ion binding 
WBGene00003643 nhr-53 GO:0005634 nucleus 
WBGene00003664 nhr-74 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00003664 nhr-74 GO:0043565 sequence-specific DNA binding 
WBGene00003664 nhr-74 GO:0003707 steroid hormone receptor activity 
WBGene00003664 nhr-74 GO:0003700 transcription factor activity 
WBGene00003664 nhr-74 GO:0008270 zinc ion binding 
WBGene00003664 nhr-74 GO:0005634 nucleus 
WBGene00003670 nhr-80 GO:0009792 embryonic development ending in birth or egg 
hatching 
WBGene00003670 nhr-80 GO:0007275 multicellular organismal development 
WBGene00003670 nhr-80 GO:0000003 reproduction 
WBGene00003670 nhr-80 GO:0045923 positive regulation of fatty acid metabolic 
process 
WBGene00003670 nhr-80 GO:0040010 positive regulation of growth rate 
WBGene00003670 nhr-80 GO:0045944 positive regulation of transcription from RNA 
polymerase II promoter 
WBGene00003670 nhr-80 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00003670 nhr-80 GO:0043565 sequence-specific DNA binding 
WBGene00003670 nhr-80 GO:0003707 steroid hormone receptor activity 
WBGene00003670 nhr-80 GO:0003700 transcription factor activity 
WBGene00003670 nhr-80 GO:0008270 zinc ion binding 
WBGene00003670 nhr-80 GO:0005634 nucleus 
WBGene00003608 nhr-9 GO:0040010 positive regulation of growth rate 
WBGene00003608 nhr-9 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00003608 nhr-9 GO:0043565 sequence-specific DNA binding 
WBGene00003608 nhr-9 GO:0003707 steroid hormone receptor activity 
WBGene00003608 nhr-9 GO:0003700 transcription factor activity 
WBGene00003608 nhr-9 GO:0008270 zinc ion binding 
WBGene00003608 nhr-9 GO:0005634 nucleus 
WBGene00003689 nhr-99 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00003689 nhr-99 GO:0043565 sequence-specific DNA binding 
WBGene00003689 nhr-99 GO:0003707 steroid hormone receptor activity 
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WBGene00003689 nhr-99 GO:0003700 transcription factor activity 
WBGene00003689 nhr-99 GO:0008270 zinc ion binding 
WBGene00003689 nhr-99 GO:0005634 nucleus 
WBGene00004013 pha-4 GO:0030154 cell differentiation 
WBGene00004013 pha-4 GO:0060573 cell fate specification involved in pattern 
specification 
WBGene00004013 pha-4 GO:0008340 determination of adult life span 
WBGene00004013 pha-4 GO:0009792 embryonic development ending in birth or egg 
hatching 
WBGene00004013 pha-4 GO:0048598 embryonic morphogenesis 
WBGene00004013 pha-4 GO:0040007 growth 
WBGene00004013 pha-4 GO:0040035 hermaphrodite genitalia development 
WBGene00004013 pha-4 GO:0032038 myosin II heavy chain binding 
WBGene00004013 pha-4 GO:0002119 nematode larval development 
WBGene00004013 pha-4 GO:0060465 pharynx development 
WBGene00004013 pha-4 GO:0000003 reproduction 
WBGene00004013 pha-4 GO:0040010 positive regulation of growth rate 
WBGene00004013 pha-4 GO:0040018 positive regulation of multicellular organism 
growth 
WBGene00004013 pha-4 GO:0045727 positive regulation of translation 
WBGene00004013 pha-4 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00004013 pha-4 GO:0043565 sequence-specific DNA binding 
WBGene00004013 pha-4 GO:0016563 transcription activator activity 
WBGene00004013 pha-4 GO:0003700 transcription factor activity 
WBGene00004013 pha-4 GO:0040011 locomotion 
WBGene00004013 pha-4 GO:0005634 nucleus 
WBGene00004024 php-3 GO:0003677 DNA binding 
WBGene00004024 php-3 GO:0045449 regulation of transcription 
WBGene00004024 php-3 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00004024 php-3 GO:0043565 sequence-specific DNA binding 
WBGene00004024 php-3 GO:0003700 transcription factor activity 
WBGene00004024 php-3 GO:0030528 transcription regulator activity 
WBGene00004024 php-3 GO:0005634 nucleus 
WBGene00004194 prx-5 GO:0008340 determination of adult life span 
WBGene00004194 prx-5 GO:0009792 embryonic development ending in birth or egg 
hatching 
WBGene00004194 prx-5 GO:0040007 growth 
WBGene00004194 prx-5 GO:0002119 nematode larval development 
WBGene00004194 prx-5 GO:0005488 binding 
WBGene00004194 prx-5 GO:0040010 positive regulation of growth rate 
WBGene00004194 prx-5 GO:0019915 lipid storage 
WBGene00004194 prx-5 GO:0016558 protein import into peroxisome matrix 
WBGene00004194 prx-5 GO:0000268 peroxisome targeting sequence binding 
WBGene00004773 sem-4  GO:0048333 mesodermal cell differentiation 
WBGene00004773 sem-4  GO:0042692 muscle cell differentiation 
WBGene00004773 sem-4  GO:0014016 neuroblast differentiation 
WBGene00004773 sem-4  GO:0018991 oviposition 
WBGene00004773 sem-4  GO:0003676 nucleic acid binding 
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WBGene00004773 sem-4  GO:0040010 positive regulation of growth rate 
WBGene00004773 sem-4  GO:0008270 zinc ion binding 
WBGene00004773 sem-4  GO:0048675 axon extension 
WBGene00004773 sem-4  GO:0005622 intracellular 
WBGene00012735 sptf-3 GO:0010171 body morphogenesis 
WBGene00012735 sptf-3 GO:0040002 collagen and cuticulin-based cuticle 
development 
WBGene00012735 sptf-3 GO:0008340 determination of adult life span 
WBGene00012735 sptf-3 GO:0009792 embryonic development ending in birth or egg 
hatching 
WBGene00012735 sptf-3 GO:0040007 growth 
WBGene00012735 sptf-3 GO:0040035 hermaphrodite genitalia development 
WBGene00012735 sptf-3 GO:0002009 morphogenesis of an epithelium 
WBGene00012735 sptf-3 GO:0002119 nematode larval development 
WBGene00012735 sptf-3 GO:0000003 reproduction 
WBGene00012735 sptf-3 GO:0003676 nucleic acid binding 
WBGene00012735 sptf-3 GO:0008270 zinc ion binding 
WBGene00012735 sptf-3 GO:0040011 locomotion 
WBGene00012735 sptf-3 GO:0006898 receptor-mediated endocytosis 
WBGene00012735 sptf-3 GO:0005622 intracellular 
WBGene00011956 T23F11.4 GO:0008270 zinc ion binding 
WBGene00011956 T23F11.4 GO:0019915 lipid storage 
WBGene00011956 T23F11.4 GO:0005622 intracellular 
WBGene00020823 T26A5.8 GO:0009792 embryonic development ending in birth or egg 
hatching 
WBGene00020823 T26A5.8 GO:0000003 reproduction 
WBGene00020823 T26A5.8 GO:0003677 DNA binding 
WBGene00020823 T26A5.8 GO:0043565 sequence-specific DNA binding 
WBGene00020823 T26A5.8 GO:0035046 pronuclear migration 
WBGene00020823 T26A5.8 GO:0005622 intracellular 
WBGene00006380 tab-1 GO:0003677 DNA binding 
WBGene00006380 tab-1 GO:0045449 regulation of transcription 
WBGene00006380 tab-1 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00006380 tab-1 GO:0043565 sequence-specific DNA binding 
WBGene00006380 tab-1 GO:0003700 transcription factor activity 
WBGene00006380 tab-1 GO:0030528 transcription regulator activity 
WBGene00006380 tab-1 GO:0005634 nucleus 
WBGene00007732 tag-347 GO:0005488 binding 
WBGene00007732 tag-347 GO:0003677 DNA binding 
WBGene00007732 tag-347 GO:0005634 nucleus 
WBGene00006553 tbx-34 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00006553 tbx-34 GO:0003700 transcription factor activity 
WBGene00006553 tbx-34 GO:0005634 nucleus 
WBGene00006744 unc-4 GO:0007400 neuroblast fate determination 
WBGene00006744 unc-4 GO:0003677 DNA binding 
WBGene00006744 unc-4 GO:0050770 regulation of axonogenesis 
WBGene00006744 unc-4 GO:0050803 regulation of synapse structure and activity 
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WBGene00006744 unc-4 GO:0045449 regulation of transcription 
WBGene00006744 unc-4 GO:0006355 regulation of transcription, DNA-dependent 
WBGene00006744 unc-4 GO:0043565 sequence-specific DNA binding 
WBGene00006744 unc-4 GO:0003700 transcription factor activity 
WBGene00006744 unc-4 GO:0030528 transcription regulator activity 
WBGene00006744 unc-4 GO:0030424 axon 
WBGene00006744 unc-4 GO:0040011 locomotion 
WBGene00006744 unc-4 GO:0007416 synaptogenesis 
WBGene00006744 unc-4 GO:0005634 nucleus 
WBGene00013796 Y116A8C.19  GO:0003676 nucleic acid binding 
WBGene00013796 Y116A8C.19  GO:0008270 zinc ion binding 
WBGene00012471 Y17G7B.20  GO:0010171 body morphogenesis 
WBGene00012471 Y17G7B.20  GO:0000003 reproduction 
WBGene00012471 Y17G7B.20  GO:0040010 positive regulation of growth rate 
WBGene00012471 Y17G7B.20  GO:0040018 positive regulation of multicellular organism 
growth 
WBGene00021374 Y37E11B.1  GO:0003676 nucleic acid binding 
WBGene00021374 Y37E11B.1  GO:0008270 zinc ion binding 
WBGene00021374 Y37E11B.1  GO:0005622 intracellular 
WBGene00013128 Y52B11A.9  GO:0010171 body morphogenesis 
WBGene00013128 Y52B11A.9  GO:0009792 embryonic development ending in birth or egg 
hatching 
WBGene00013128 Y52B11A.9  GO:0040007 growth 
WBGene00013128 Y52B11A.9  GO:0002009 morphogenesis of an epithelium 
WBGene00013128 Y52B11A.9  GO:0002119 nematode larval development 
WBGene00013128 Y52B11A.9  GO:0000003 reproduction 
WBGene00013128 Y52B11A.9  GO:0040010 positive regulation of growth rate 
WBGene00013128 Y52B11A.9  GO:0008270 zinc ion binding 
WBGene00013128 Y52B11A.9  GO:0005840 ribosome 
WBGene00013128 Y52B11A.9  GO:0003735 structural constituent of ribosome 
WBGene00013128 Y52B11A.9  GO:0040011 locomotion 
WBGene00013128 Y52B11A.9  GO:0006412 translation 
WBGene00013128 Y52B11A.9  GO:0005622 intracellular 
WBGene00021816 Y53G8AR.9  GO:0002009 morphogenesis of an epithelium 
WBGene00021816 Y53G8AR.9  GO:0003676 nucleic acid binding 
WBGene00021816 Y53G8AR.9  GO:0008270 zinc ion binding 
WBGene00013236 Y56A3A.18  GO:0009792 embryonic development ending in birth or egg 
hatching 
WBGene00013236 Y56A3A.18  GO:0040007 growth 
WBGene00013236 Y56A3A.18  GO:0002119 nematode larval development 
WBGene00013236 Y56A3A.18  GO:0000003 reproduction 
WBGene00013236 Y56A3A.18  GO:0040010 positive regulation of growth rate 
WBGene00013236 Y56A3A.18  GO:0008270 zinc ion binding 
WBGene00013236 Y56A3A.18  GO:0006898 receptor-mediated endocytosis 
WBGene00013236 Y56A3A.18  GO:0005622 intracellular 
WBGene00012385 Y5F2A.4  GO:0003676 nucleic acid binding 
WBGene00012385 Y5F2A.4  GO:0008270 zinc ion binding 
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WBGene00012385 Y5F2A.4  GO:0005622 intracellular 
WBGene00013970 ZK337.2 GO:0003676 nucleic acid binding 
WBGene00013970 ZK337.2 GO:0008270 zinc ion binding 
WBGene00013970 ZK337.2 GO:0005622 intracellular 
WBGene00018099 ztf-28 GO:0008270 zinc ion binding 
WBGene00018099 ztf-28 GO:0005622 intracellular 
WBGene00016905 ztf-3 GO:0040002 collagen and cuticulin-based cuticle 
development 
WBGene00016905 ztf-3 GO:0009792 embryonic development ending in birth or egg 
hatching 
WBGene00016905 ztf-3 GO:0003676 nucleic acid binding 
WBGene00016905 ztf-3 GO:0040018 positive regulation of multicellular organism 
growth 
WBGene00016905 ztf-3 GO:0008270 zinc ion binding 
WBGene00016905 ztf-3 GO:0005622 intracellular 
WBGene00020399 ztf-4 GO:0003676 nucleic acid binding 
WBGene00020399 ztf-4 GO:0000166 nucleotide binding 
WBGene00020399 ztf-4 GO:0008270 zinc ion binding 
WBGene00020399 ztf-4 GO:0005622 intracellular 
WBGene00006999 zyx-1 GO:0000003 reproduction 
WBGene00006999 zyx-1 GO:0005515 protein binding 
WBGene00006999 zyx-1 GO:0008270 zinc ion binding 
WBGene00006999 zyx-1 GO:0015629 actin cytoskeleton 
WBGene00006999 zyx-1 GO:0005925 focal adhesion 
WBGene00006999 zyx-1 GO:0055120 striated muscle dense body 
WBGene00006999 zyx-1 GO:0017151 DEAD/H-box RNA helicase binding 
WBGene00006999 zyx-1 GO:0031430 M band 
WBGene00006999 zyx-1 GO:0005634 nucleus 
 
